Exploring how RNA machines control gene expression at a molecular level
The RNA nanomachines of gene expression dissected at the single molecule level
This study is exploring how RNA molecules work to control gene activity, which could help develop new treatments for patients by understanding how these tiny machines function in our cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11058410 on NIH RePORTER |
What this research studies
This research investigates the intricate mechanisms by which RNA molecules function as machines to regulate gene expression. Using advanced single molecule fluorescence microscopy, the team aims to understand how different RNA structures influence the processes of transcription and translation. By examining various RNA types, including ribozymes and riboswitches, the research seeks to uncover new insights into RNA's role in cellular functions and gene regulation. Patients may benefit from the findings as they could lead to novel therapeutic strategies targeting RNA mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or diseases where gene expression plays a critical role.
Not a fit: Patients with conditions unrelated to RNA function or gene expression may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that manipulate RNA functions to improve gene expression regulation in various diseases.
How similar studies have performed: Previous research has shown promising results in understanding RNA mechanisms, suggesting that this approach could yield significant advancements in the field.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Walter, Nils G — University of Michigan at Ann Arbor
- Study coordinator: Walter, Nils G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.